American Society of Nephrology (ASN)

Kidney Damage From COVID-19 Linked to Higher Risk of In-Hospital Death

Highlight

  • In an analysis of patients hospitalized with COVID-19, kidney damage associated with the infectious disease was linked with a higher risk of dying during hospitalization.

Newswise — Washington, DC (September 22, 2020) — Many individuals who develop COVID-19 experience kidney damage, or acute kidney injury (AKI). Investigators recently evaluated the incidence, risk factors, and prognosis of AKI in adults with COVID-19. Their findings appear in an upcoming issue of CJASN.

The study was conducted in Tongji hospital in Wuhan, China, which was assigned responsibility for the treatment of severe COVID-19 cases by the local government. Investigators led by Gang Xu, PhD and Shuwang Ge, MD analyzed information pertaining to 1,392 patients who tested positive for the virus that causes COVID-19.

The team found that, in patients with COVID-19, AKI is uncommon but is linked with a high risk of in-hospital mortality. Seven percent of patients developed AKI during hospitalization, many within 7 days after admission. The in-hospital mortality rate was 10% in patients without AKI vs.72% in patients with AKI. After adjusting for potential confounding factors, AKI was associated with a 5-times higher odds of dying while in the hospital. Also, the risk of death was higher with greater severity of AKI. 

Factors associated with a higher risk of AKI included severe COVID-19 disease, high blood levels of creatinine (an indicator of kidney dysfunction), low blood levels of certain immune cells, and high blood levels of a protein fragment indicative of elevated blood clot formation and breakdown.

“Prior to this study, there was limited information concerning epidemiological characteristics and outcomes associated with AKI in patients with COVID-19,” said Dr. Xu. “Our results indicate that AKI is strongly associated with mortality, and that careful monitoring of AKI is necessary early in the course of infection.”

An accompanying editorial notes that additional studies are needed to investigate why AKI is linked with such a high risk of premature death in patients with COVID-19.

Study co-authors include Yichun Cheng, MD, Ran Luo, MD, Xu Wang, MD, Kun Wang, MD, Meng Zhang, PhD, Zhixiang Wang, MD, Lei Dong, MD, Junhua Li, PhD, and Ying Yao, PhD.

Disclosures: The authors reported no financial disclosures.

The article, titled “The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019,” will appear online at http://cjasn.asnjournals.org/ on September 22, 2020, doi: 10.2215/CJN.04650420.

The editorial, titled “COVID 19-Associated AKI: An Evolving Picture,” will appear online at http://cjasn.asnjournals.org/ on September 22, 2020, doi: 10.2215/CJN.13600820.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 21,000 members representing 131 countries. For more information, visit www.asn-online.org.

 

# # #




Filters close

Showing results

110 of 3765
Released: 23-Oct-2020 4:55 PM EDT
Woman recovering from COVID-19 shares experience as monoclonal antibody clinical trial participant
University of Texas Health Science Center at Houston

When Christina Loville tested positive for the coronavirus, she was terrified. She decided to channel her fear into researching COVID-19 treatments, where she discovered a local clinical trial led by experts at The University of Texas Health Science Center at Houston (UTHealth).

Released: 23-Oct-2020 4:30 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Released: 23-Oct-2020 1:50 PM EDT
Are we really “rounding the corner" when it comes the coronavirus pandemic?
Newswise

“We’re rounding the turn,” Trump said during the debate. This implies a meaningful improvement. We rate this claim as false. On that very same day the U.S. recorded 77,000 new cases, according to NBC News. This tops the previous high that had been set in July. We may be learning to "live with it," as Trump mentioned, but this is not an improvement.

Newswise: 246719_web.jpg
Released: 23-Oct-2020 12:50 PM EDT
NRL researchers evaluate ultraviolet sources, combat COVID-19
United States Naval Research Laboratory

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

Released: 23-Oct-2020 12:05 PM EDT
COVID-19 anxiety linked to body image issues
Anglia Ruskin University

A new study has found that anxiety and stress directly linked to COVID-19 could be causing a number of body image issues amongst women and men.

Newswise: 246747_web.jpg
Released: 23-Oct-2020 11:45 AM EDT
Eliminating COVID-19: What the world can learn from NZ and Taiwan
University of Otago

Both Taiwan and New Zealand have successfully eliminated COVID-19 with world-leading pandemic responses. By taking a particularly proactive approach, Taiwan's response was probably the most effective and least disruptive of any country's, researchers say.

Released: 23-Oct-2020 11:00 AM EDT
Healthcare's earthquake: Lessons from COVID-19
Beth Israel Deaconess Medical Center

The COVID-19 pandemic has fundamentally disrupted U.S. healthcare organizations.

Released: 23-Oct-2020 10:50 AM EDT
COVID-19 lockdown reduced mental health, sleep, exercise
Pennington Biomedical Research Center

A first-of-its-kind global survey shows the initial phase of the COVID-19 lockdown dramatically altered our personal habits, largely for the worse.

Released: 23-Oct-2020 10:45 AM EDT
New Data on Increasing Cloth Mask Effectiveness
Society for Risk Analysis (SRA)

A new study published in Risk Analysis, “Reinventing cloth masks in the face of pandemics,” by Stephen Salter, P.Eng., describes how Effective Fiber Mask Programs (EFMPs) can help communities find a balance between the economy and curbing community spread.


Showing results

110 of 3765

close
1.04749